Fri 6/5/2020 00:07 ET
DJIA26281.8213.140.05%TELCO173.391.140.66%GOLD1731.6018.351.06%Shanghai2911.587.570.26%
S&P 5003112.3510.580.34%BANKS375.8812.483.32%OIL35.341.634.61%BITCOIN9801.316.860.07%
NASDAQ9615.8166.350.69%PHARM609.724.390.72%US/EU1.130.000.04%Futures3057.2519.260.63%
Welcome Stranger!  Please sign up or log in to enable additional features.Sign Up | Mail | Log In
Forum - YM BioSciences - YMI   

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  
From: crainiac (Rep: 4194)Date: 12/09/2012 19:59
Forum: YM BioSciences - Msg #3441Thread #673482866 (Rec: 0)
YM BioSciences Reports Phase I/II Data for JAK Inhibitor CYT387 in Myelofibrosis at ASH 2012

http://www.marketwatch.com/story/ym-biosciences-reports-phase-iii-data-for-jak-inhibitor-cyt387-in-myelofibrosis-at-ash-2012-2012-12-09-17183150

What would you like to do? Message: Endorse | Bookmark | Report AbuseUser crainiac: Reward | Watch | IgnoreYMI: Ignore

Msg Top | Msg List | < Prev | Next > | Post New | Reply | Privately | Search | Add YMI
  

TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.